phenylacetylglutamine has been researched along with Diabetes Mellitus, Type 2 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, J; Ma, X; Qiu, L; Tang, Y; Yu, S; Zhang, L; Zou, Y | 1 |
| Cai, M; Chen, Q; Han, X; Jin, S; Li, Y; Lu, B; Lu, H; Tian, J; Wang, Z; Xu, J; Yan, Z | 1 |
| Barrios, C; Beaumont, M; Bell, JT; Clark, A; Goodrich, JK; Ley, RE; Menni, C; Pallister, T; Pascual, J; Spector, TD; Villar, J | 1 |
3 other study(ies) available for phenylacetylglutamine and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method.
Topics: Chromatography, Liquid; Diabetes Mellitus, Type 2; Glutamine; Humans; Isotopes; Methylamines; Myocardial Infarction; Tandem Mass Spectrometry | 2022 |
Phenylacetylglutamine as a novel biomarker of type 2 diabetes with distal symmetric polyneuropathy by metabolomics.
Topics: Biomarkers; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Metabolomics; Polyneuropathies | 2023 |
Gut-Microbiota-Metabolite Axis in Early Renal Function Decline.
Topics: Adult; Aged; Aged, 80 and over; Body Mass Index; Clostridiales; Cresols; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diseases in Twins; Feces; Female; Fermentation; Gastrointestinal Microbiome; Glomerular Filtration Rate; Glutamine; Humans; Indican; Kidney Diseases; Male; Metabolome; Microbiota; Middle Aged; Ribotyping; Sulfuric Acid Esters | 2015 |